Foreign Clinical Trials: FDA Oversight To Include More Training, Data Collection

Changes to FDA's policy for monitoring foreign clinical trials appear imminent after the Department of Health and Human Services Inspector General recommended the agency increase its oversight of data gathered outside the U.S